Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Trypanocidal structure- activity relationship in 9-thioalkylacridines]

N Bsiri1, C Johnson, M Kayirere

  • 1GERCTOP, URA CNRS, Faculté de Pharmacie, Marseille.

Annales Pharmaceutiques Francaises
|January 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of the Midi Parasep® SF technique for the detection of L1 larvae of <i>Angiostrongylus cantonensis</i> in faeces of infected rats.

Journal of helminthology·2023
Same author

Characterization and functionality of two members of the SPFH protein superfamily, prohibitin 1 and 2 in Leishmania major.

Parasites & vectors·2018
Same author

Intraperitoneal administration of the anti-IL-23 antibody prevents the establishment of intestinal nematodes in mice.

Scientific reports·2018
Same author

Renal Transplant Immunosuppression in Patients With Hemolytic Uremic Syndrome: Four Case Reports.

Transplantation proceedings·2018
Same author

Self-adjuvanting C18 lipid vinil sulfone-PP2A vaccine: study of the induced immunomodulation against <i>Trichuris muris</i> infection.

Open biology·2017
Same author

Non-Heart-Beating Donor Kidney Transplantation Survival Is Similar to Donation After Brain Death: Comparative Study With Controls in a Regional Program.

Transplantation proceedings·2016

Researchers synthesized and tested nine thioalkylacridinones against Trypanosoma cruzi (T. cruzi). Structure-activity relationships were analyzed to find key features for antiparasitic effectiveness.

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Organic Synthesis

Context:

  • Chagas disease, caused by the parasite Trypanosoma cruzi (T. cruzi), remains a significant global health concern.
  • Current treatments for Chagas disease have limitations, necessitating the development of novel therapeutic agents.
  • Acridinone derivatives have shown promise as potential antiparasitic compounds.

Purpose:

  • To synthesize a novel series of 9-thioalkylacridinone derivatives.
  • To evaluate the in vitro antiparasitic activity of these compounds against T. cruzi.
  • To establish structure-activity relationships (SAR) to guide the design of more potent T. cruzi inhibitors.

Summary:

  • Nine novel 9-thioalkylacridinone compounds were successfully synthesized.

Related Experiment Videos

  • In vitro assays demonstrated varying degrees of antiparasitic activity against T. cruzi.
  • Detailed SAR analysis identified critical structural elements influencing the observed activity, highlighting specific thioalkyl chain modifications.

    • Impact:

    • Provides a foundation for the rational design of new anti-T. cruzi drug candidates.
    • Identifies key structural features for optimizing antiparasitic potency and selectivity.
    • Contributes to the ongoing search for effective treatments against Chagas disease.